Covered recipient · General Payments record
TUSHAR TRIVEDI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2023
$381.09
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $152.64 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $36.22 | 2 |
| Horizon Pharma plc | $25.12 | 1 |
| Cala Health, Inc. | $16.42 | 1 |
| Alnylam Pharmaceuticals Inc. | $16.07 | 1 |
| Amneal Pharmaceuticals LLC | $15.94 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.60 | 1 |
| SK Life Science, Inc. | $14.52 | 1 |
| PFIZER INC. | $13.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $16.07 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006117023 | CMS |
| Amneal Pharmaceuticals LLC | $15.94 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053542325 | CMS |
| Cala Health, Inc. | $16.42 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051479499 | CMS |
| Horizon Therapeutics plc | $25.12 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987084633 | CMS |
| Novartis Pharmaceuticals Corporation | $14.60 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993285317 | CMS |
| PFIZER INC. | $13.75 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049140635 | CMS |
| SK Life Science, Inc. | $14.52 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054853027 | CMS |
| UCB, Inc. | $20.02 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021782863 | CMS |
| UCB, Inc. | $16.20 | 07/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021782860 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.